Hounaida Mahfoud on Hemoperitoneum in Case of Type 3 VWD
Hounaida Mahfoud, Assistant Professor at Faculty of Medicine and Pharmacy of Rabat, shared on LinkedIn:
”Delighted to share the publication of our article on a difficult case managed successfully, thanks to my mentor Pr Mohamed El Khorassani and the dedicated ICU team at Hôpital de Maternité Souissi.
Honoured to be part of this work.
Hemoperitoneum secondary to a ruptured hemorrhagic C is usually a benign and self-limiting condition, but in women with type 3 von Willebrand disease (VWD), it may evolve into a severe and potentially life-threatening event due to the inability to achieve spontaneous hemostasis.
We report a case of a 30-year-old woman with type 3 VWD who presented with acute pelvic pain and profound anemia.
Transvaginal ultrasonography and MRI demonstrated a ruptured hemorrhagic ovarian cyst associated with a large hemoperitoneum.
Despite the extent of bleeding, the patient remained hemodynamically stable and was managed conservatively.
Treatment consisted of von Willebrand factor replacement, blood transfusion, analgesia, and close clinical and radiological monitoring.
Her condition improved progressively, with normalization of hemoglobin levels, resolution of symptoms, and significant regression of the hemoperitoneum on follow-up imaging.
No surgical intervention was required. Managing ovarian cyst rupture in severe VMD is particularly challenging, as surgical intervention carries substantial hemorrhagic risk.
Conservative management, when supported by adequate hemostatic therapy, can be both safe and effective, preserving ovarian function and reducing perioperative morbidity.
This case underscores the importance of individualized, multidisciplinary care to optimize management strategies in women with severe bleeding disorders.”
Read the full article here.
Article: Conservative Management of Hemoperitoneum Due to a Ruptured Hemorrhagic Ovarian Cyst in Type 3 von Willebrand Disease
Authors: Hounaida Mahfoud, Rim Laaboudi, Mohamed Elkhorassani, Nabil Elachhab, Samir Bargach
Stay updated on all scientific advances with Hemostasis Today.
-
May 31, 2026, 11:51Seema Dawood: Principles of Blood Smear Examination and Interpretation
-
May 31, 2026, 11:45Maria Cherska: Should We Continue Relying on Risk Prediction or Shift to Direct Detection of Atherosclerosis?
-
May 31, 2026, 11:34Jose Rubio: Advancing Lupus Care Through Community and Partnership
-
May 31, 2026, 11:23Eugene Fan: Advancing Peripheral Blood Film Analysis with Artificial Intelligence
-
May 31, 2026, 11:07Mohamed Al Nasef: A Cohort Analysis of Increased Perioperative Thrombosis Risk in Neonates with TGA
-
May 31, 2026, 10:40Akshat Jain: Pleasure to Present at the Insightful Latin America Hemophilia Meeting
-
May 31, 2026, 10:32Pall T. Onundarson: The 3-Decade Journey of Ultrasound-Enhanced Fibrinolysis in PE
-
May 31, 2026, 10:22La’Ron Browne: Balancing Clinical Benefits and Healthcare Costs in Hydroxyurea Management of SCD in Brazil
-
May 31, 2026, 10:09Purusotham Chippala: A 47-Year-Old Stroke Survivor Taught Me Something Modern Healthcare Keeps Ignoring